REGiMMUNE
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
820 Heinz Ave, Berkeley, California, 947...Phone Number
(408) 616-9735Website
www.regimmune.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About REGiMMUNE
REGiMMUNE specializes in developing treatments for immune disorders by harnessing the patient's immune system to induce tolerance and achieve anti-tumor responses. Their focus is on immune modulation and regulatory T cells. The company aims to provide innovative solutions for patients suffering from various immune-related conditions. Their intended clients include individuals with immune disorders and those seeking advanced therapeutic options.Explore more
REGiMMUNE Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is REGiMMUNE your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when REGiMMUNE launches new products
Check if REGiMMUNE has recently received funding, and reach out quickly before it becomes old news!
Click to see if REGiMMUNE had a recent Job posting/layoffs
Funding: Get notified immidiatlly once REGiMMUNE has new funding data
REGiMMUNE, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if REGiMMUNE is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at REGiMMUNE
Earning: See what the market has to say on REGiMMUNE recently announced quarterly report
Recommended Actions
Find VP level buyers at REGiMMUNE
Find 2 more new buyers
Compare Similar Companies to REGiMMUNE
Compare insights from companies similar to REGiMMUNE, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
REGiMMUNE is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
REGiMMUNE is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about REGiMMUNE.
REGiMMUNE financials insights
Gather financial insights about REGiMMUNE, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Angel/Seed
$1.6M
2007
Series A
$4.2M
2008
Series B
$6M
2012
Series C
$5M
2014
Series D
$9.2M
REGiMMUNE Tech Stack
A closer look at the technologies used by REGiMMUNE
See more technologies
REGiMMUNE News & Media
REGiMMUNE Presented Positive Results of RGI-2001 in the Reduction of Acute GvHD from Phase 2b Study at the 2022 ASH Annual Meeting
TAIPEI, Taiwan--(BUSINESS WIRE)--REGiMMUNE Limited, a clinical-stage biopharmaceutical company developing innovative immunotherapies for immune disorders and cancer, today announced the positive results of their Phase 2b clinical trial for the prevention of acute graft-versus-host disease (aGvHD) after allogeneic hematopoietic cell transplantation (HCT) at the 2022 American Society of Hematology (ASH) Annual Meeting. RGI-2001 activates Regulatory T-cells (Tregs) through a novel mechanism that mREGiMMUNE to Present Results from the Phase 2b Study of RGI-2001 at the 2022 American Society of Hematology Annual Meeting
TAIPEI, Taiwan--(BUSINESS WIRE)--REGiMMUNE Limited will be presenting at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans, Louisiana on December 12, 2022.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding REGiMMUNE
Sign Up For FreeTo access detailed company insights
REGiMMUNE specializes in developing treatments for immune disorders by harnessing the patient's immune system to induce tolerance and achieve anti-tumor responses. Their focus is on immune modulation and regulatory T cells. The company aims to provide innovative solutions for patients suffering from various immune-related conditions. Their intended... Read More
